Ningbo David Medical Device Co Ltd
Ningbo David Medical Device Co., Ltd. engages in the research and development, production, and sales of pediatric childcare equipment, surgical instruments and other products worldwide. The company provides infant incubators, transport incubators, infant radiant warmers, neonate bilirubin phototherapy equipment, infant resuscitators, etc. It also offers other products, such as infusion pumps, tra… Read more
Ningbo David Medical Device Co Ltd (300314) - Net Assets
Latest net assets as of September 2025: CN¥1.22 Billion CNY
Based on the latest financial reports, Ningbo David Medical Device Co Ltd (300314) has net assets worth CN¥1.22 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.44 Billion) and total liabilities (CN¥225.02 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.22 Billion |
| % of Total Assets | 84.41% |
| Annual Growth Rate | 18.02% |
| 5-Year Change | 22.53% |
| 10-Year Change | 67.4% |
| Growth Volatility | 62.02 |
Ningbo David Medical Device Co Ltd - Net Assets Trend (2008–2024)
This chart illustrates how Ningbo David Medical Device Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ningbo David Medical Device Co Ltd (2008–2024)
The table below shows the annual net assets of Ningbo David Medical Device Co Ltd from 2008 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.17 Billion | +0.42% |
| 2023-12-31 | CN¥1.16 Billion | +9.83% |
| 2022-12-31 | CN¥1.06 Billion | +6.94% |
| 2021-12-31 | CN¥990.53 Million | +3.88% |
| 2020-12-31 | CN¥953.52 Million | +15.04% |
| 2019-12-31 | CN¥828.85 Million | +4.56% |
| 2018-12-31 | CN¥792.71 Million | +1.85% |
| 2017-12-31 | CN¥778.30 Million | +3.97% |
| 2016-12-31 | CN¥748.55 Million | +7.26% |
| 2015-12-31 | CN¥697.90 Million | +4.33% |
| 2014-12-31 | CN¥668.97 Million | +6.50% |
| 2013-12-31 | CN¥628.16 Million | +6.09% |
| 2012-12-31 | CN¥592.09 Million | +260.48% |
| 2011-12-31 | CN¥164.25 Million | +48.94% |
| 2010-12-31 | CN¥110.28 Million | +38.60% |
| 2009-12-31 | CN¥79.57 Million | -3.51% |
| 2008-12-31 | CN¥82.46 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ningbo David Medical Device Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2224.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥614.79 Million | 52.62% |
| Common Stock | CN¥288.00 Million | 24.65% |
| Other Components | CN¥265.53 Million | 22.73% |
| Total Equity | CN¥1.17 Billion | 100.00% |
Ningbo David Medical Device Co Ltd Competitors by Market Cap
The table below lists competitors of Ningbo David Medical Device Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Zinwell Corporation
TW:2485
|
$175.23 Million |
|
Launch One Acquisition Corp. Unit
NASDAQ:LPAAU
|
$175.27 Million |
|
Svedbergs i Dalstorp AB (publ)
ST:SVED-B
|
$175.31 Million |
|
TotalEnergies EP Gabon S.A.
PA:EC
|
$175.32 Million |
|
Berkeley Energy Ltd
PINK:BKLRF
|
$175.19 Million |
|
Ningbo Yibin Electronic Technology Co. Ltd. Cl A
SHE:001278
|
$175.18 Million |
|
LifeMD Inc
NASDAQ:LFMD
|
$175.14 Million |
|
Jinglv Envi Science & Tech Co
SHE:001230
|
$175.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ningbo David Medical Device Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,163,472,411 to 1,168,317,369, a change of 4,844,958 (0.4%).
- Net income of 57,263,314 contributed positively to equity growth.
- Dividend payments of 51,840,000 reduced retained earnings.
- Other comprehensive income decreased equity by 86,831,291.
- Other factors increased equity by 86,252,935.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥57.26 Million | +4.9% |
| Dividends Paid | CN¥51.84 Million | -4.44% |
| Other Comprehensive Income | CN¥-86.83 Million | -7.43% |
| Other Changes | CN¥86.25 Million | +7.38% |
| Total Change | CN¥- | 0.42% |
Book Value vs Market Value Analysis
This analysis compares Ningbo David Medical Device Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.31x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 35.72x to 3.31x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | CN¥0.38 | CN¥13.44 | x |
| 2009-12-31 | CN¥0.37 | CN¥13.44 | x |
| 2010-12-31 | CN¥0.51 | CN¥13.44 | x |
| 2011-12-31 | CN¥0.76 | CN¥13.44 | x |
| 2012-12-31 | CN¥2.23 | CN¥13.44 | x |
| 2013-12-31 | CN¥2.18 | CN¥13.44 | x |
| 2014-12-31 | CN¥2.37 | CN¥13.44 | x |
| 2015-12-31 | CN¥2.49 | CN¥13.44 | x |
| 2016-12-31 | CN¥2.65 | CN¥13.44 | x |
| 2017-12-31 | CN¥2.65 | CN¥13.44 | x |
| 2018-12-31 | CN¥2.75 | CN¥13.44 | x |
| 2019-12-31 | CN¥2.88 | CN¥13.44 | x |
| 2020-12-31 | CN¥3.31 | CN¥13.44 | x |
| 2021-12-31 | CN¥3.44 | CN¥13.44 | x |
| 2022-12-31 | CN¥3.68 | CN¥13.44 | x |
| 2023-12-31 | CN¥4.02 | CN¥13.44 | x |
| 2024-12-31 | CN¥4.06 | CN¥13.44 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ningbo David Medical Device Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.90%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.87%
- • Asset Turnover: 0.37x
- • Equity Multiplier: 1.21x
- Recent ROE (4.90%) is below the historical average (14.49%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 30.27% | 17.67% | 0.73x | 2.34x | CN¥16.61 Million |
| 2009 | 36.39% | 19.33% | 0.73x | 2.58x | CN¥21.00 Million |
| 2010 | 34.99% | 21.72% | 0.75x | 2.15x | CN¥27.56 Million |
| 2011 | 32.86% | 26.10% | 0.75x | 1.68x | CN¥37.54 Million |
| 2012 | 12.48% | 28.88% | 0.39x | 1.10x | CN¥14.66 Million |
| 2013 | 10.20% | 29.49% | 0.32x | 1.07x | CN¥1.26 Million |
| 2014 | 8.01% | 23.60% | 0.32x | 1.07x | CN¥-13.29 Million |
| 2015 | 6.44% | 20.48% | 0.29x | 1.08x | CN¥-24.86 Million |
| 2016 | 8.30% | 23.46% | 0.32x | 1.12x | CN¥-12.69 Million |
| 2017 | 6.04% | 15.48% | 0.35x | 1.11x | CN¥-30.80 Million |
| 2018 | 3.63% | 9.59% | 0.34x | 1.12x | CN¥-50.46 Million |
| 2019 | 7.49% | 17.41% | 0.37x | 1.16x | CN¥-20.83 Million |
| 2020 | 14.28% | 29.64% | 0.41x | 1.18x | CN¥40.84 Million |
| 2021 | 8.10% | 16.92% | 0.41x | 1.17x | CN¥-18.85 Million |
| 2022 | 9.19% | 19.24% | 0.40x | 1.18x | CN¥-8.57 Million |
| 2023 | 12.69% | 23.87% | 0.45x | 1.18x | CN¥31.26 Million |
| 2024 | 4.90% | 10.87% | 0.37x | 1.21x | CN¥-59.57 Million |
Industry Comparison
This section compares Ningbo David Medical Device Co Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,879,733,462
- Average return on equity (ROE) among peers: 24.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ningbo David Medical Device Co Ltd (300314) | CN¥1.22 Billion | 30.27% | 0.18x | $175.22 Million |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $792.82 Million | 25.77% | 0.17x | $318.98 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $482.51 Million | 20.84% | 0.32x | $2.79 Billion |
| Double Medical Technology Inc (002901) | $224.61 Million | 43.10% | 0.32x | $404.40 Million |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $1.42 Million | 98.49% | 2.27x | $281.14 Million |
| Lepu Medical Tech Beijing (300003) | $12.27 Billion | 14.01% | 0.69x | $2.71 Billion |
| INKON Life Technology Co Ltd (300143) | $1.81 Billion | -20.17% | 0.37x | $637.77 Million |
| Edan Instruments Inc (300206) | $1.26 Billion | 7.37% | 0.15x | $501.55 Million |
| Guangdong Biolight Meditech Co Ltd (300246) | $504.27 Million | 13.31% | 0.36x | $360.97 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.44 Billion | 2.82% | 0.20x | $267.10 Million |
| Sinocare Inc (300298) | $17.42 Million | 41.15% | 0.68x | $952.60 Million |